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The development of new molecular tools and computational
methods for the study of human genetic diseases and traits has
led to a wave of excitement about the implications of genetic
discoveries. These advancements apply not only to rare genetic
disorders but also to common complex genetic traits, and they
have the potential to improve health and prevent disease. The
implementation of such discoveries inevitably requires multi-
disciplinary expertise, which is clearly represented in Human
Genome Epidemiology, edited by Muin Khoury, Julian Little,
and Wylie Burke. The diverse academic backgrounds of the
contributors reflect the multidisciplinary nature of this field.
Although the focus of this book is on public health genetics,
several aspects of human genetics research are covered, in-
cluding some statistical genetics concepts as well as ethical,
legal, and social issues.
This book is in the same vein as a previously published book
entitled Genetics and Public Health in the 21st Century and
is a complement to the book Fundamentals of Genetic Epi-
demiology, which also has Muin Khoury as its leading editor.
In the present book, Khoury, Little, and Burke define the term
“Human Genome Epidemiology” (HuGE) as “the application
of the epidemiologic approach to the human genome in re-
lation to health and disease.” Although the book covers a wide
continuum from gene discovery to the development and ap-
plication of genetic tests, the focus of this book is on the ap-
proach to take after genes for complex traits have been iden-
tified. This book has been organized into four sections, which
are presented and briefly commented on below.
Part I of the book, “Fundamentals,” opens with “Human
Genome Epidemiology: Scope and Strategies” (chapter 1), pro-
viding an introduction to the field of HuGE research. Chapter
2 briefly presents the fundamentals of technologies and the
methods for gene discovery, including descriptions of various
types of genetic markers, genotyping methods, and proteomic
technologies. In chapter 3, the most common approaches for
determining the genetic basis of diseases and for identifying
the genes underlying complex traits are briefly presented. Eth-
ical, legal, and social issues related to HuGE studies, including
topics such as informed consent, are presented in chapter 4.
In Part II, “Methods and Approaches I: Assessing Disease
Associations and Interactions,” epidemiologic design strategies
and analytic methods used in genetic association studies are
presented. This includes the assessment of gene-gene interac-
tion and gene-environment interaction, as well as challenges
inherent in such studies. Factors to consider in specimen se-
lection for genetic epidemiologic studies, as well as some qual-
ity-assurance measures, are discussed in chapter 5. A very clear
and concise review of statistical issues in the design and anal-
ysis of gene-disease association studies is presented in chapter
6. Chapters 7–9 present various fundamental units of epide-
miologic analyses of studies that relate health outcomes and
issues relevant to gene-environment studies. This section ends
with recommendations for reporting and reviewing HuGE
studies (chapter 10).
Part III, “Methods and Approaches II: Assessing Genetic
Tests for Disease Prevention,” addresses the application of ge-
netic epidemiologic methods to both clinical and public health
settings. Various issues surrounding the evaluation and imple-
mentation of genetic testing in populations are covered, in-
cluding analytic and clinical validity and the clinical utility of
genetic tests (chapter 11). In particular, chapter 12 presents an
evidence-based approach to genetic testing in populations, and
chapter 13 presents a model process for evaluating data on
newly developed genetic tests, aiming to provide summary data
that could be useful, for example, to policy makers and public
health administrators. Chapter 14 is on pharmacogenomics,
and chapter 15 covers the integration of genetics into ran-
domized controlled trials. Chapters 16 and 17 present a U.S.
perspective on the clinical use of genetic tests and a U.K. per-
spective on the development of genetics services, respectively.
Part IV, “Case Studies: Using Human Genome Epidemiology
Information to Improve Health” (chapters 18–29), provides
an illustration of concepts discussed earlier in the book, in-
cluding examples of single-gene disorders as well as complex
diseases. Each example presented in this section highlights the
necessity of obtaining population-level information required
for health policy development and novel approaches to clinical
practice.
The strengths of this book lie in its comprehensive treatment
of this timely subject and in the richness of applied examples
and clear tables. Overall, the book provides a broad covering
of aspects related to public health genetics. It presents the cur-
rent knowledge, identifies gaps in HuGE studies, and provides
recommendations on the challenging work that remains to be
done. The practical information included in this book is quite
useful in providing direction in several areas. For example, a
clear table in chapter 5 compares the various types of DNA
specimens that can be used for epidemiologic studies, the quan-
tity of DNA that can be collected from each kind of sample,
and the advantages and disadvantages of each type of speci-
men. Chapter 10 presents a checklist for reporting and ap-
praising studies of gene association and characterization stud-
ies. Chapter 16 discusses the evidence needed for practice
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guidelines related to genetic testing, as well as strategies avail-
able to clinicians and policy makers to accomplish this task.
A relative weakness of the book, which may be inherent in
such a complex, multidisciplinary, multi-authored effort, is
that some sections are redundant. For example, population
stratification is presented and discussed in eight chapters, and
clinical validity and utility is covered in several chapters as
well. Moreover, some chapters, such as chapters 7 and 10, are
partially copied from published review articles. Finally, given
that this book is multidisciplinary and is likely to have readers
that may be unfamiliar with some of the genetics terminology,
a glossary of the terms used in this book would have been
beneficial.
This book, Human Genome Epidemiology, can be used as
a reference tool or a self-teaching resource. It will be useful to
epidemiologists and public health researchers who are inter-
ested in the applications of genetics research, as well as teachers
in these fields who are looking for examples to help students
understand concepts related to public health genetics. This
book highlights the considerations that should be made prior
to translating gene discoveries into a public health context. It
could also be useful to clinicians and policy makers who want
an overview of the present stage of research in this area. I
would not, however, recommend this volume as a textbook,
because, despite being comprehensive, it does not provide suf-
ficient detail in individual areas to ensure in-depth understand-
ing by students. This book finds its niche by presenting genetics
from a broad public health perspective, an area in which books
are currently relatively scarce.
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